Next 10 |
home / stock / medp / medp articles
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.83% on an annualized basis producing an average annual return o...
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 33.11% on an annualized basis producing an average annual return o...
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.19% on an annualized basis producing an average annual return o...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. Shares of Ecolab Inc. (NYSE: ECL) rose during Tuesday&rs...
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 24.18% on an annualized basis producing an average annual return o...
August J Troendle, CEO at Medpace Hldgs (NASDAQ:MEDP), reported a large insider sell on November 29, according to a new SEC filing. What Happened:...
August J Troendle, CEO at Medpace Hldgs (NASDAQ:MEDP), reported a large insider sell on November 22, according to a new SEC filing. What Happened:...
August J Troendle, CEO at Medpace Hldgs (NASDAQ:MEDP), reported a large insider sell on November 16, according to a new SEC filing. What Happened:...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Chicken Soup for the Soul Entertainment Inc. (CSSE) rose 43.1% to $0.218 on volume of 39,190,339 shares Amesite Inc. (AMST) rose 100.0% to $4.0001 on volume of 36,290,765 shares Tesla Inc. (TSLA) rose 10.7% to $160.21 on volume of 32,...
2024-04-23 06:00:08 ET David Windley from Jefferies issued a price target of $450.00 for MEDP on 2024-04-23 02:21:00. The adjusted price target was set to $450.00. At the time of the announcement, MEDP was trading at $376.26. The overall price target consensus is at $452...
Revenue of $511.0 million in the first quarter of 2024 increased 17.7% from revenue of $434.1 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $615.6 million in the first quarter of 2024, representing an increase o...